Literature DB >> 10832647

Localization and characterization of the ligand-binding domain of the fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi.

Mary Meehan1, Deirdre A Muldowney1, Naomi J Watkins1, Peter Owen1.   

Abstract

The group C streptococcus Streptococcus equi subsp. equi possesses a 498-residue major cell-wall-associated protein (FgBP) which binds horse fibrinogen (Fg), reacts with convalescent horse serum and protects against lethal S. equi challenge in a small animal model. In the present study, analysis of a panel of 17 purified N- and C-terminal FgBP truncates by ligand affinity blotting and SDS-PAGE revealed that the region required for maximum binding of Fg extended over the first half of the mature protein. The C-terminal two-thirds of this domain is predicted to be alpha-helical coiled-coil and the N-terminal one-third to possess non-coiled-coil single strands. Residues at the extreme N-terminus and within the coiled-coil region are both required for ligand binding. A high incidence of alpha-helical coiled-coil structure also seems to be responsible in part for the aberrant mobility of FgBP on SDS gels. The efficiency with which FgBP binds Fg from different animal species decreases in the order horse > mouse, pig > rat > sheep, dog, bovine, human. Binding to horse Fg is inversely related to temperature over the range 45-4 degrees C and is independent of Ca2+ ions. MS analysis provided corroborative evidence that FgBP is covalently linked to the cell wall peptidoglycan.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832647     DOI: 10.1099/00221287-146-5-1187

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  8 in total

1.  Prominent Binding of Human and Equine Fibrinogen to Streptococcus equi subsp. zooepidemicus Is Mediated by Specific SzM Types and Is a Distinct Phenotype of Zoonotic Isolates.

Authors:  René Bergmann; Maria-Christin Jentsch; Albrecht Uhlig; Uwe Müller; Mark van der Linden; Magnus Rasmussen; Andrew Waller; Maren von Köckritz-Blickwede; Christoph Georg Baums
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

2.  Sequence variation of the SeM gene of Streptococcus equi allows discrimination of the source of strangles outbreaks.

Authors:  Charlotte Kelly; Maxine Bugg; Carl Robinson; Zoe Mitchell; Nick Davis-Poynter; J Richard Newton; Keith A Jolley; Martin C J Maiden; Andrew S Waller
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

3.  The novel fibrinogen-binding protein FbsB promotes Streptococcus agalactiae invasion into epithelial cells.

Authors:  Heike Gutekunst; Bernhard J Eikmanns; Dieter J Reinscheid
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

4.  A fibrinogen-binding lipoprotein contributes to the virulence of Haemophilus ducreyi in humans.

Authors:  Margaret E Bauer; Carisa A Townsend; Ryan S Doster; Kate R Fortney; Beth W Zwickl; Barry P Katz; Stanley M Spinola; Diane M Janowicz
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

5.  Lineages of Streptococcus equi ssp. equi in the Irish equine industry.

Authors:  Emma Moloney; Kerrie S Kavanagh; Tom C Buckley; Jakki C Cooney
Journal:  Ir Vet J       Date:  2013-06-04       Impact factor: 2.146

6.  A common theme in interaction of bacterial immunoglobulin-binding proteins with immunoglobulins illustrated in the equine system.

Authors:  Melanie J Lewis; Mary Meehan; Peter Owen; Jenny M Woof
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

7.  Identification and molecular characterisation of a fibrinogen binding protein from Streptococcus iniae.

Authors:  Justice C F Baiano; Reiny A Tumbol; Aarti Umapathy; Andrew C Barnes
Journal:  BMC Microbiol       Date:  2008-04-23       Impact factor: 3.605

Review 8.  The Role of Gram-Positive Surface Proteins in Bacterial Niche- and Host-Specialization.

Authors:  Amy C Pickering; J Ross Fitzgerald
Journal:  Front Microbiol       Date:  2020-10-29       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.